Whan In Pharm Co.,Ltd. (KRX:016580)
South Korea
· Delayed Price · Currency is KRW 10,110
-330 (-3.16%)
Mar 9, 2026, 3:30 PM KST
Whan In Pharm Revenue
Whan In Pharm had revenue of 65.74B KRW in the quarter ending September 30, 2025, a decrease of -3.49%. This brings the company's revenue in the last twelve months to 256.32B, up 1.83% year-over-year. In the year 2024, Whan In Pharm had annual revenue of 259.60B with 12.68% growth.
Revenue (ttm)
256.32B
Revenue Growth
+1.83%
P/S Ratio
0.60
Revenue / Employee
426.49M
Employees
601
Market Cap
154.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 259.60B | 29.20B | 12.68% |
| Dec 31, 2023 | 230.39B | 31.46B | 15.81% |
| Dec 31, 2022 | 198.93B | 21.16B | 11.90% |
| Dec 31, 2021 | 177.78B | 6.07B | 3.54% |
| Dec 31, 2020 | 171.71B | 12.53B | 7.87% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2012 | Pro | Pro | Pro |
| Dec 31, 2011 | Pro | Pro | Pro |
| Dec 31, 2010 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ilsung Is | 66.51B |
| Dongwha Pharm.Co.,Ltd | 493.33B |
| Daihan Pharmaceutical | 209.00B |
| Hana Pharm | 139.33B |
| SAMSUNG PHARM. Co., LTD. | 44.29B |
| HANDOK | 516.37B |
| Jeil Pharma Holdings | 707.15B |
| Kyongbo Pharmaceutical | 252.20B |